Inclusion Criteria:
  -  MRI positive - abnormal area detected
  -  Patient re-evaluated in the TOH Prostate CAC (Cancer Assessment Centre) for planning of targeted biopsy
  -  Signed Consent
Exclusion Criteria:
  -  MRI negative - no abnormal area detected
  -  Patient with a prior diagnosis of prostate cancer enrolled in active surveillance